Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2024 Earnings Call Transcript March 4, 2025 Operator: Good afternoon, and ...
Revenue: US$37.9m (down 4.3% from FY 2023). Net loss: US$6.48m (loss widened by 3.2% from FY 2023). US$0.46 loss per share (further deteriorated from US$0.44 loss in FY 2023). The primary driver ...
The Company provided the above adjusted supplemental financial performance measures, which are considered "non-GAAP" financial measures under applicable SEC rules and regulations. These financial ...
NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Cumberland Pharmaceuticals Inc. (CPIX) on Tuesday reported a loss of $1.9 million in its fourth quarter. The Nashville, Tennessee-based company ...
Good afternoon, and welcome to Cumberland Pharmaceuticals Fourth Quarter 2024 Financial Report and Company Update. This call is being recorded at company’s request and will be archived on its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results